Your browser doesn't support javascript.
loading
Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.
Imamura, Michie; Higuchi, Osamu; Maeda, Yasuhiro; Mukaino, Akihiro; Ueda, Mitsuharu; Matsuo, Hidenori; Nakane, Shunya.
Afiliação
  • Imamura M; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8555, Japan.
  • Higuchi O; Department of Clinical Research, National Hospital Organization Nagasaki Kawatana Medical Center, Nagasaki 859-3615, Japan.
  • Maeda Y; Department of Clinical Research, National Hospital Organization Nagasaki Kawatana Medical Center, Nagasaki 859-3615, Japan.
  • Mukaino A; Department of Molecular Neurology and Therapeutics, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
  • Ueda M; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8555, Japan.
  • Matsuo H; Department of Neurology, National Hospital Organization Nagasaki Kawatana Medical Center, Nagasaki 859-3615, Japan.
  • Nakane S; Department of Molecular Neurology and Therapeutics, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Int J Mol Sci ; 21(24)2020 Dec 17.
Article em En | MEDLINE | ID: mdl-33348803

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Canais de Potássio Corretores do Fluxo de Internalização / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Canais de Potássio Corretores do Fluxo de Internalização / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article